Month: September 2018

Ready to Use Pharmaceutical Packaging: Trends and Opportunities

The ready to use of pharmaceutical primary packaging has emerged as a promising alternative to conventional primary packaging, adding significant value to streamline pharmaceutical fill / finish operations. These packaging components eliminate multiple steps in the overall fill finish manufacturing (mainly washing, sterilizing and preparing containers), thereby, helping improve operational efficiencies in compliance to existing 

Cold Chain Logistics: Opportunities in Cell Therapies and Vaccines

Presently, a wide variety of pharmaceutical products, such as biologics, vaccines, human organs for transplantation and certain conventional pharmacological interventions as well, are temperature sensitive and require freezing / cryogenic holding temperatures. In fact, over 95% of all approved biologics and 90% of all vaccines are cold chain logistics dependent.  Stakeholders in this segment have

Extractables and Leachables Testing: Emerging Opportunities

During drug product manufacturing and fill / finish, it is important to consider not only the impurity profiles of the drugs, but also identify potential sources of contamination in the containers / packaging material used. due to high variability in the type of impurities (organic (volatile, non-volatile or semi- volatile compounds) or inorganic (metals or

ADC Manufacturing: Current Landscape and Growth Opportunities

Antibody drug conjugates (ADCs) are one of the most popular classes of targeted therapeutic agents and have captured the attention of both large and small pharmaceutical companies, and academic / research institutions across the world. Owing to the fact that these novel conjugates act as cytoxic drugs and HPAPI molecules, their manufacturing requires elaborate technical

Neurostimulation Devices: Competitive Landscape, Market Evolution and Opportunity Areas

Extensive research in the field of Neurostimulation has demonstrated the potential of this technique in providing therapeutic relief to a number of patients, who have developed resistance to conventional medication. Since the introduction of the first neurostimulation therapy in 1960s, their numerous observed benefits, such as reversible and minimally invasive nature of the procedures (to